A scarcity of the diabetes drug Ozempic, which is used off-label for weight loss, is predicted in Canada, according to the manufacturer’s statement on Friday.
Novo Nordisk has reported a temporary supply disruption with its one-milligram injection pen for Ozempic.
This shortage is a result of global supply constraints and an increase in demand for the drug.
Health Canada has stated that intermittent shortages are anticipated from late August to early October.
Trending Now
Canada has ‘game plan’ in case of authoritarian shift in the U.S. after 2024 election: Joly
Bruce Willis’ wife gives tearful update on his dementia battle
Both Health Canada and Novo Nordisk have confirmed that the 0.25 mg and 0.5 mg doses of Ozempic are still available for patients with Type 2 diabetes.
Pharmacists are encouraged to limit refill prescriptions to a 30-day supply.
Denial of responsibility!VigourTimes is an automatic aggregator of Global media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessary action within 24 hours.
Denial of responsibility!Vigour Times is an automatic aggregator of Global media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, and all materials to their authors. For any complaint, please reach us at – [email protected]. We will take necessary action within 24 hours.
